Recent news and posts
Bi-weekly snapshot of market access and HEOR project work at MTRC – Edition 26th of October 2026
Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.
From the week of October 26th, we are planning to work on 13 projects, including:
Reimbursement
- Working on a market access strategy for minimally invasive treatment in the ophthalmology area in the Netherlands
- Working on educational sessions on the market access landscape for medical aids in several European countries
HEOR
- Delivering validation of a health economic model in the cardiology area
- Delivering an adaptation of a health economic model for an imaging diagnostic system in the UK
- Developing a cost-consequence and budget impact model for minimally invasive treatment for atrial fibrillation
- Working on the development of a health economic model for in vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain
- Working on a systematic literature review and meta-analysis for an in vitro diagnostic test
- Working on the development of a clinical evidence dossier for a neuromodulation technology in the chronic pain area
- Working on the development of a value dossier for technology in the cardiovascular area
- Working on the development of a stakeholder engagement and objection-handling framework in the HEOR field
- Working on a within-trial economic analysis in the cardiology area
- Working on systematic literature reviews on the clinical effectiveness and safety of treatment technologies in the neurology area
- Working on a review of clinical practice guidelines for the management of neurological and pain conditions
Let us know if you need any market access or HEOR support for your medical technology in Europe.